Business & Regulation Trends & Forecasts, Supply Chain, Advanced Medicine, Drug Delivery, Technology and Equipment

The Cell Preservation Society

Experts discuss the trends, challenges, and advantages in cryopreservation use for cell and gene therapies

08/19/2024 | Video

Therapy developers and researchers in the advanced medicines sector are doing their utmost every day to improve and accelerate the journey of their products from the bench to the bedside. The supporting transport, logistics, and storage specialists tasked with the preservation and delivery of those products are working just as hard alongside them to improve their own products and services – and keep pace with a rapidly developing modality. To facilitate that next stage requires a new, advanced kind of collaboration, as well as new advances in cryopreservation technologies and capabilities. With players in both industry sectors agreeing to be part of a kind of symbiotic relationship, deputy editor Rob Coker speaks to a panel of experts to discuss the trends, challenges, advantages, and future of advanced therapies in an age witnessing an increasing use of cryopreservation.

Stella Vnook is the CEO of Likarda, a biotech company developing technologies to improve cell therapy delivery, potency, and sustainability. After helping to develop and commercialize a method of coating cells with inert hydrogels to maintain cell viability, Vnook earned a place on our 2024 Power List.

Priya Baraniak is the co-founder and Chief Business Officer of OrganaBio, a contract technology development and manufacturing organization enabling the development and commercialization of cell therapies. Baraniak’s biomedical engineering expertise has culminated in a broad understanding of the cell therapy supply chain, various laboratory techniques, QA/QC measures, regulatory filings, and technology transfer.

Trevor Smith is the Senior Marketing Manager for Cell & Gene Therapy at Terumo Blood and Cell Technologies. With expertise in T cell expansion on automated bioreactor systems, he has developed a deep understanding of scaling up through process development, GMP lab design, training, and optimized cell collections.

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.